HMGB1 and Schnyder corneal dystrophy: These data present what we believe is a novel mechanism of crosstalk between inflammatory and thrombotic signaling and have implications for both the therapeutic targeting of HMGB1 and P2Y12 receptors in healthy individuals and those with SCD and other thromboinflammatory diseases.